Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2004-01-07
2010-11-09
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S036000, C514S673000, C514S054000
Reexamination Certificate
active
07829543
ABSTRACT:
Disclosed are methods of treating bacterial infections including those caused by multidrug resistant bacteria using polyamine efflux pump inhibiting compounds, including for example N-benzylated polyazaalkanes, N-benzylated polyaminoalkanes, or mixed N-benzylated poly(aza/amino)alkanes, optionally in combination with other drugs such as antibiotics, as well as pharmaceutical compositions thereof.
REFERENCES:
patent: 2916485 (1959-12-01), Frohardt et al.
patent: 5900406 (1999-05-01), Von Ahsen et al.
patent: 6068972 (2000-05-01), Levy
patent: 6136771 (2000-10-01), Taylor et al.
patent: 6204297 (2001-03-01), Tracy et al.
patent: 6326391 (2001-12-01), Markham et al.
patent: 6346391 (2002-02-01), Oethinger et al.
patent: 6436980 (2002-08-01), Leger et al.
patent: 2515629 (1975-04-01), None
patent: 021150 (1980-03-01), None
patent: 349224 (1990-01-01), None
patent: 349224 (1990-01-01), None
patent: WO 96/33285 (1996-10-01), None
patent: WO 97/31917 (1997-09-01), None
patent: WO 99/17760 (1999-04-01), None
patent: WO 99/37667 (1999-07-01), None
patent: WO 00/01714 (2000-01-01), None
patent: WO 02/09758 (2002-02-01), None
patent: WO 2004/024140 (2004-03-01), None
patent: WO 2004/062674 (2004-07-01), None
Fujii et al., The Journal of Antibiotics, (Tokyo), May 1968, vol. 21. No. 5, pp. 340-349.
Forsee et al.,Journal of the American Chemical Society, (1935), vol. 57, pp. 1788-1799 (Abstract Sent).
Stetter et al., Chemische Berichte (1973), vol. 106, No. 8, pp. 2523-2529. (Abstract Sent).
Schulze et al., DD 248500 A1, Aug. 12, 1987.(Abstract Sent).
Arct et al. (Przemysl Chemiczny (1962), 41, 582-6 (Abstract Sent)).
Eckstein et al. (Bulletin de l'Academie Polonaise des Sciences, Serie des Sciences Chimiques (1962), 10, 487-92) (Abstract Sent).
Reichert et al. (Arch. Pharm.(1944), 282, 109-12)(Abstract Sent).
Stetter et al., Chemische Berichte (1973), vol. 106, No. 8, pp. 2523-2529. (Abstract Sent).
Bollinger et al. (Conference on Coordination Chemistry (1995), 15th (Current Trends in Coordination Chemistry), 361-6) (Abstract sent).
Arcamone, F.M., et al.. “New semisynthetic aminosidine derivatives.”G Ital Chemioter. Jan.-Dec. 1977; 24(1-2):77-81.
Aires, J.R., et al., “Involvement of an active efflux system in the natural resistance ofPseudomonas aeruginosato aminoglycosides.”Antimicrob Agents Chemother. Nov. 1999; 43(11):2624-8.
Cassinelli, G., et al., “Semisynthetic aminoglycoside antibiotics. I. New reactions of paromomycin and synthesis of its 2′-N-ethylderivative.”J Antibiot(Tokyo). Apr. 1978, 31(4):379-81.
Chen, H.Y., et al., “Identification and analysis of the sap genes fromVibrio fischeribelonging to the ATP-binding cassette gene family required for peptide transport and resistance to antimicrobial peptides.”Biochem Biophys Res Commun. Mar. 24, 2000; 269(3):743-8.
Elkins, C.A., et al., “Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD ofEscherichia coliis determined predominantly by two large periplasmic loops.”J Bacteriol. Dec. 2002; 184(23):6490-8.
Fath, M.J., et al., “ABC transporters: bacterial exporters.”Microbiol Rev. Dec. 1993; 57(4):995-1017.
Fujii, A., et al. “Synthesis of tetra-N-phenylalkylkanamycins and their antimicrobial activities.”J Antibiot(Tokyo). May 1968;21(5):340-9.
Jones, R.N., et al., “Comparative spectrum and activity of NVP-PDF386 (VRC4887), a new peptide deformylase inhibitor.”J Antimicrob Chemother. Jan. 2003; 51(1):157-61.
Levy, S.B., “Active efflux mechanisms for antimicrobial resistance.”Antimicrob Agents Chemother. Apr. 1992; 36(4):695-703.
Ma, D., et al., “Molecular cloning and characterization of acrA and acrE genes ofEscherichia coli.” J Bacteriol. Oct. 1993; 175(19):6299-313.
Nikaido, H., “Multidrug efflux pumps of gram-negative bacteria.”J Bacteriol. Oct. 1996; 178(20):5853-9.
Nikaido, H., et al.. “Multidrug efflux pump AcrAB ofSalmonella typhimuriumexcretes only those beta-lactam antibiotics containing lipophilic side chains.”J Bacteriol. Sep. 1998; 180(17):4686-92.
Ouellette, M., et al., “Microbial multidrug-resistance ABC transporters.”Trends Microbiol. Oct. 1994; 2(10):407-11.
Rengaraju, S., et al., “3-N-methylparomomycin I produced by a Streptomyces.”J Antibiot(Tokyo). Nov. 1986; 39(11):1598-601.
Rosenberg, E.Y., et al., “AcrD ofEscherichia coliis an aminoglycoside efflux pump.”J Bacteriol. Mar. 2000; 182(6):1754-6.
Sanchez, L., et al., “The acrAB homolog ofHaemophilus influenzaecodes for a functional multidrug efflux pump.”J Bacteriol. Nov. 1997; 179(21):6855-7.
Spratt, B.G., “Resistance to antibiotics mediated by target alterations.”Science. Apr. 15, 1994; 264(5157):388-93.
Stermitz, F.R., et al., “Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor.”Proc Natl Acad Sci U S A. Feb. 15, 2000; 97(4):1433-7.
Sutcliffe,Curr. Opin. Anti-infect. Invest. Drugs. 1999; 1:403-12.
Taniyama, H., et al., “Antibiotics aminosidin. II. Some amino derivatives of aminosidin and their biological activity.”Chem Pharm Bull(Tokyo). Mar. 1973; 21(3):609-15.
Tomitori, H., et al., “Identification of a gene for a polyamine transport protein in yeast.”J Biol Chem. Feb. 5, 1999; 274(6):3265-7.
Westbrock-Wadman, S., et al., “Characterization of aPseudomonas aeruginosaefflux pump contributing to aminoglycoside impermeability.”Antimicrob Agents Chemother. Dec. 1999; 43(12):2975-83.
Woolridge, D.P., et al., “Characterization of a novel spermidine/spermine acetyltransferase, BItD, fromBacillus subtilis.” Biochem J. Jun. 15, 1999; 340 ( Pt.3):753-8.
Woolridge, D.P., et al., “Efflux of the natural polyamine spermidine facilitated by theBacillus subtilismultidrug transporter Blt.”J Biol Chem. Apr. 4, 1997; 272(14):8864-6.
Alekshun Michael N.
Nelson Mark L.
Hanley Elizabeth A.
Henry Michael C
Jiang Shaojia Anna
McCarter & English LLP
Paratek Pharmaceuticals, Inc.
LandOfFree
Substituted polyamines as inhibitors of bacterial efflux pumps does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted polyamines as inhibitors of bacterial efflux pumps, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted polyamines as inhibitors of bacterial efflux pumps will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4245723